Handelsavisen
prelaunch
Companies Healthcare 5889.T
58
5889.T Tokyo Stock Exchange Medical Equipment, Supplies & Distribution

5889.T

¥2 400,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
58,6B JPY
P/E
EV / Rev
Div yield
3,77 %
Op margin
32,0 %
ROE
20,8 %
Net margin
20,3 %
Debt / equity
0,86
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare services and equipment industry, primarily generating revenue through the sale of medical equipment, supplies, and distribution services.

Business. 5889.T is a healthcare company operating within the Medical Equipment, Supplies & Distribution industry. The firm generates revenue through the sale of medical products and equipment. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not available in the provided data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY1 analysts
1 buy0 hold0 sell
Avg 12m price target

Analyst recommendations

1 analysts · consensus Buy
Buy1
Hold0
Sell0
12-month price target
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
1 analysts · indicative
Ownership
not yet wired
Profitability
20,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 5889.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 5889.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    5889.T is a healthcare company operating within the Medical Equipment, Supplies & Distribution industry. The firm generates revenue through the sale of medical products and equipment. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not available in the provided data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company maintains a market price of 2167.0 JPY, with a market capitalization of 52,886,025,060.0 JPY, indicating a moderate valuation relative to its equity and tangible book value. The price-to-earnings ratio of 13.98 and a price-to-book ratio of 2.91 suggest the company is trading at a premium to its book value but at a reasonable multiple of earnings. The company's liquidity position is characterized by a current ratio of 0.44, which is below 1, indicating potential short-term liquidity constraints. The company's free cash flow of 2,822,000,000.0 JPY supports its operations and provides flexibility for reinvestment or shareholder returns.

    Profitability metrics show a return on equity of 20.8% and a return on assets of 9.48%, both of which are strong indicators of efficient capital utilization and asset management. The company's operating income of 5,957,000,000.0 JPY and net income of 3,783,000,000.0 JPY reflect a healthy margin structure, with a gross profit of 14,672,000,000.0 JPY supporting these results. The debt-to-equity ratio of 0.86 suggests a balanced capital structure, with long-term debt of 15,604,000,000.0 JPY and total equity of 18,187,000,000.0 JPY.

    The company's revenue of 18,640,000,000.0 JPY is derived from its core operations in the healthcare services and equipment industry, with no disclosed segment or geographic breakdown provided in the available data. The absence of detailed segment or geographic data limits the ability to assess revenue concentration or diversification.

    The company's growth trajectory is supported by a free cash flow of 2,822,000,000.0 JPY and a capital expenditure of -721,000,000.0 JPY, indicating a net outflow for investment in operations. Analyst estimates suggest a mean recommendation of 2.00, with one buy rating and no strong buy or sell ratings, indicating a neutral to slightly positive outlook. The mean EPS estimate of 205.90 JPY is higher than the last actual EPS of 156.81 JPY, suggesting potential for earnings growth.

    The company's risk profile is characterized by a medium liquidity risk and a low dilution risk, with key flags indicating that net cash is negative after subtracting total debt. The company's capital structure includes long-term debt of 15,604,000,000.0 JPY and total liabilities of 21,724,000,000.0 JPY, with total assets of 39,911,000,000.0 JPY. The absence of detailed risk factors or dilution sources in the available data limits the ability to assess specific risk drivers.

    Recent events and filings are not detailed in the available data, limiting the ability to assess the company's recent performance or strategic initiatives. The company's financial performance and risk profile suggest a stable but moderate growth outlook, with a focus on maintaining liquidity and managing debt levels.

    Key takeaways
    • The company has a strong return on equity of 20.8%, indicating efficient use of shareholder capital.
    • The company's liquidity position is constrained, with a current ratio of 0.44, suggesting potential short-term financial stress.
    • The company's debt-to-equity ratio of 0.86 indicates a balanced capital structure, with manageable leverage.
    • Analysts have a neutral to slightly positive outlook, with a mean recommendation of 2.00 and one buy rating.
    • The company's free cash flow of 2,822,000,000.0 JPY provides flexibility for reinvestment or shareholder returns.
    • The company's risk profile is characterized by medium liquidity risk and low dilution risk.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥2 400,00
    Market cap
    ¥52.89B
    Enterprise value
    ¥65.44B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    12.2x
    P / B
    2.9x
    P / Tangible book
    2.9x
    Tangible book
    ¥18.19B
    Net cash
    -¥12.55B
    Current ratio
    0.4
    Debt / equity
    0.9
    ROA
    9.5%
    ROE
    20.8%
    Cash conversion
    142.0%
    CapEx / revenue
    -3.9%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    205,90
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    1
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-04 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate205,90
    Revenueno estimateno estimate22,6B JPY
    Operating incomeno estimateno estimateno estimate
    Full-year consensus mean (period as reported by source) · consensus in JPY. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy0
    Buy1
    Hold0
    Sell0
    Strong sell0
    EPS surprise
    −23,8 %
    reported vs consensus · miss
    Revenue surprise
    −17,5 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin32,0 %Above P75
    Net Margin20,3 %Above P75
    ROE20,8 %Best in class
    Capex / Rev-3,9 %Above median
    D/E0,86Bottom quartile
    Cash Conv1,42Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • 5889.T Market data — financials · 2026-05-26
    • Japan Eyewear Holdings Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    5889.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage